Cwa Asset Management Group, LLC Gilead Sciences, Inc. Transaction History
Cwa Asset Management Group, LLC
- $2.58 Billion
- Q3 2025
A detailed history of Cwa Asset Management Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cwa Asset Management Group, LLC holds 54,812 shares of GILD stock, worth $6.8 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
54,812
Previous 65,743
16.63%
Holding current value
$6.8 Million
Previous $7.29 Million
16.52%
% of portfolio
0.24%
Previous 0.32%
Shares
33 transactions
Others Institutions Holding GILD
# of Institutions
2,371Shares Held
1.01BCall Options Held
8.63MPut Options Held
7.39M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...